Please login to the form below

I have forgotten my password

France ignores EMA and suspends Bayer's Diane 35

ANSM

National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict

ClinTec International expands into Turkey

CRO says new office will bolster its presence in the Middle East and North Africa

Royalty Pharma raises Elan bid as deals keep coming

Values Elan at about $6.5bn

Pfizer pulls late-stage trial of cancer drug in NHL

Inotuzumab ozogamicin fails to show survival benefit in phase III

Actavis to buy Warner Chilcott in $8.5bn deal

Combined company will have annual revenues of about $11bn

Healthcare at Home and QED partner on orphan diseases

OrphanReach alliance will see companies provide product lifecycle services

New vortioxetine studies reinforce efficacy in depression

Supports marketing applications from Takeda and Lundbeck

India puts cost controls on medicines

Drugs (Prices Control) Order 2013 reduces price of hundreds of drugs

Sanofi reconsiders closure plans in Toulouse after government pressure

Report says research site can remain open with minimal job losses

Chasing the cure for Parkinson’s disease

Research for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms

From paralysis to analysis: the journey to multichannel marketing

To make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier
Bringing trial data out of the shadows

Transparency of clinical trial data has become a hotly disputed topic recently, how the industry at large will respond is still not clear, but as the noise grows louder, reputations

EMA says Bayer's Diane 35 should remain on European market

Agency investigation concludes acne treatment's benefits outweigh its risks
PMEA 2013 opens for entry

Programme recognises responsible marketing and business practice in the healthcare industry
J&J's Simponi wins FDA approval in ulcerative colitis

Adds to rheumatoid arthritis, psoriatic arthritis and active ankylosing spondylitis indications in the US
Sanofi plans to file JAK2 inhibitor after positive phase III

Aiming for approval in blood cancer myelofibrosis
Bayer boosts consumer care business with Steigerwald purchase

Fuels ambition to become world leader in OTC medicines
NICE recommends Astellas' Betmiga for overactive bladder

Final draft guidance recommends Vesicare successor
Amgen and Novartis partner with biotech venture capital firm

Atlas Venture fund aims to create 15 new biotech companies

Latest appointments

Boehringer's Wolfram Carius to step down

He will be replaced by Wolfgang Baiker on the board of managing directors
Canada role for UCB's Hervé Lilliu

Appointed general manager of biopharma company’s operations in the country
Former NICE chair joins board of biotech

Sir Michael Rawlins joins board of Intra-Cellular Therapeutics
Lundbeck's Steve Turley re-elected as EMG chair

And Actelion's Robin Bhattacherjee retains vice-chair position
VC firm expands team, appoints Genzyme and Lilly veterans

New roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore

More appointments

Featured jobs

Senior Brand Manager - Harlow: Competitive
Sales Manager - Media Publishing – Cheshire: 25,000 to 35,000 per annum
UK Marketing Director: 80,000 to 100,000 per annum
Group Account Director –Healthcare Advertising: Neg

Subscribe to our email news alerts

PMHub

Add my company

Complete HealthVizion

Complete HealthVizion is a team outstanding healthcare communications experts who provide innovative strategic evidence based solutions through scientific and commercial ...

Latest intelligence

Clinical trial regulation in Mexico: Regulatory improvements make Mexico an appealing destination for clinical trials outsourcing...
How can pharma deliver returns on increased digital investment?: Independent online professional networks work best as part of a multi-channel campaign ...
The impact of Hollande's healthcare reforms in France: A tougher environment for pharma, with market access and regulatory challenges...

Quick links

Multimedia

<>